January 15, 2026: California Man Sues Novo Nordisk After Taking Ozempic and Losing His Vision A man from California has brought a lawsuit against Novo Nordisk, the company that manufactures Ozempic
Furthermore, the degradation of damaged mitochondria via enhanced mitophagy facilitates organelle renewal, mitigates mitochondrial aging, and preserves OXPHOS efficiency [47]
Until similar data exists for Retatrutide, there remains an open question about its cardiovascular safety and potential benefit, particularly given the theoretical cardiovascular considerations around glucagon receptor activation
These benefits seem to go beyond just weight loss, suggesting GLP-1s may reduce inflammation in the liver directly
This availability difference may influence your decision if needle anxiety or injection site issues have become problematic